Related references
Note: Only part of the references are listed.Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Sociodemographic disparities in the management of type 2 diabetes in the United States
Xi Tan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes
Rozalina G. McCoy et al.
JAMA NETWORK OPEN (2020)
How Are Income and Education Related to the Prevention and Management of Diabetes?
Kristin Allen et al.
JOURNAL OF AGING AND HEALTH (2020)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2019 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2019)
Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
Derek LeRoith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Adoption of New Glucose-Lowering Medications in the US-The Case of SGLT2 Inhibitors: Nationwide Cohort Study
Rozalina G. McCoy et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Kenneth W. Mahaffey et al.
CIRCULATION (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
Bernard Zinman et al.
STROKE (2017)
Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare
Jeah Jung et al.
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2017)
Synopsis of the 2017 US Department of Veterans Affairs/US Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus
Paul R. Conlin et al.
ANNALS OF INTERNAL MEDICINE (2017)
Racial and Economic Disparities in Diabetes in a Large Primary Care Patient Population
Danielle L. Heidemann et al.
ETHNICITY & DISEASE (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Optum Labs: Building A Novel Node In The Learning Health Care System
Paul J. Wallace et al.
HEALTH AFFAIRS (2014)
The Effects of Financial Pressures on Adherence and Glucose Control Among Racial/Ethnically Diverse Patients with Diabetes
Quyen Ngo-Metzger et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2012)
Socioeconomic Status and Risk of Diabetes-Related Mortality in the US
Sharon Saydah et al.
PUBLIC HEALTH REPORTS (2010)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Gender differences across racial and ethnic groups in the quality of care for diabetes
R Correa-De-Araujo et al.
WOMENS HEALTH ISSUES (2006)
Share Paper
